Navigation Links
Shamir Optical Industry Ltd. Reports Third Quarter 2008 Results
Date:11/26/2008

KIBBUTZ SHAMIR, Israel, Nov. 26 /PRNewswire-FirstCall/ -- Shamir Optical Industry Ltd. (Nasdaq: SHMR) ("Shamir"), a leading provider of innovative products and technology to the ophthalmic lens market, today announced unaudited financial results for the third quarter ended September 30, 2008.

For the quarter ended September 30, 2008, revenues increased by 16.8% to $36.1 million, compared to $30.9 million for the third quarter of 2007. Gross profit for the quarter increased by 17.5% to $19.0 million, or 52.7% of revenues, compared to gross profit of $16.2 million, or 52.3% of revenues for the same period last year.

For the quarter ended September 30, 2008, operating income was $2.9 million, or 8.2% of revenues, compared to operating income of $3.2 million, or 10.2% of revenues for the same period last year. Net income for the quarter was $2.2 million, or $0.13 per diluted share, compared to net income of $2.3 million for the comparable period in 2007. For the quarter, operating and net income were negatively impacted by approximately $0.4 million due to a one time compensation payment to the Company's former CEO.

Excluding the effects of non-cash stock-based compensation expenses, amortization of intangible assets and one-time compensation to the Company's former CEO, non-GAAP operating income was $3.8 million, or 10.4% of revenues, compared to non-GAAP operating income of $3.7 million, or 11.9% of revenues, for the same period of 2007.

Excluding the effects of non-cash stock-based compensation expenses, amortization of intangible assets and one-time compensation to the former CEO, net of tax, non-GAAP net income for the quarter increased 4.1% to $2.9 million, or $0.18 per diluted share, from $2.8 million for the comparable period in 2007.

The reconciliation of GAAP operating income and net income to non-GAAP operating income and non-GAAP net income is set forth below.

As of September 30, 2008, the Company had cash and cash equivalents, including short-term investments of $25.1 million.

Commenting on the results, Eyal Hayardeny, Chief Executive Officer of Shamir, said, "Shamir preformed well in the third quarter, particularly in light of an increasingly difficult economic environment throughout the world. We executed solidly and continued to make important inroads in many of our operating markets, with the goal of advancing the recognition for Shamir-branded products. Concurrent with these efforts, we continue to stress the importance of strict cost controls, which has always been a main component of our operating philosophy, but has become increasingly important during these difficult economic times."

Mr. Hayardeny continued, "With Altra coming under full ownership and operational control of Shamir during the quarter, we further advanced our European distribution network. In addition, we are now in a position to exact greater operational and cost efficiencies throughout our European operations. With the team we currently have in place, we are confident that we can continue to expand our footprint throughout the region and in turn gain strong returns on this investment."

Mr. Hayardeny concluded, "With the widening of the economic difficulties throughout the world, it has become increasingly difficult to forecast our sales. With that said, we still believe we will be able to meet previously announced forecasts of estimate for growth in the range of 10%-16%, based on the December 2007 exchange rates and excluding the results of our Mexican operation."

Conference Call:

Shamir has scheduled a conference call for 11:00 a.m. ET today to discuss third quarter results. To participate in the call, please dial 888-562-3356 (U.S. and Canada) or 973-582-2700 (International). The conference ID for this event is 73332398. For those unable to participate there will be replay available from 12:00 p.m. ET on November 26, 2008 through 11:59 p.m. ET, December 3, 2008. Please call: 800-642-1687 (U.S. and Canada) 706-645-9291 (International). The ID code for the replay is 73332398.

The call will be available as a live, listen-only webcast at www.kcsa.com. Please go to the KCSA website at least 15 minutes prior to the scheduled start time to register, download and install any necessary audio software. A 30-day archive of the webcast will be available approximately 2 hours after the conclusion of the live call.

About non - GAAP financial measures

This press release includes non-GAAP financial measures - non-GAAP operating income and non-GAAP net income - that exclude certain charges. The presentation of this financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management of Shamir believes that non-GAAP operating income and non-GAAP net income provides meaningful supplemental information because these numbers, which exclude the effect of non-cash stock-based compensation expenses amortization of intangible assets and one-time compensation to the former CEO, reflect our core operational results and are used by management internally to review Shamir's financial results. Shamir's management believes that amortization of intangible assets does not reflect our core operational and due to recent acquisitions these non-cash expenses becomes more material and should be excluded for non-GAAP measurement.

About Shamir

Shamir is a leading provider of innovative products and technology to the spectacle lens market. Utilizing its proprietary technology, the company develops, designs, manufactures, and markets progressive lenses to sell to the ophthalmic market. In addition, Shamir utilizes its technology to provide design services to optical lens manufacturers under service and royalty agreements. Progressive lenses are used to treat presbyopia, a vision condition where the eye loses its ability to focus on close objects. Progressive lenses combine several optical strengths into a single lens to provide a gradual and seamless transition from near to intermediate, to distant vision. Shamir differentiates its products from its competitors' primarily through lens design. Shamir's leading lenses are marketed under a variety of trade names, including Shamir Genesis(TM), Shamir Piccolo(TM), Shamir Office(TM), Shamir Nano(TM), Shamir Autograph(TM) and Shamir Smart(TM). Shamir believes that it has one of the world's preeminent research and development teams for progressive lenses, molds, and complementary technologies and tools. Shamir developed software dedicated to the design of progressive lenses. This software is based on Shamir's proprietary mathematical algorithms that optimize designs of progressive lenses for a variety of activities and environments. Shamir also has created software tools specifically designed for research and development and production requirements, including Eye Point Technology software, which simulates human vision.

SafeHarbor Statement

Statements concerning Shamir's business outlook or future economic performance; product introductions and plans and objectives related thereto; and assumptions made or expectations as to any future events, conditions, performance or other matters, are "forward-looking statements" as that term is defined under U.S. federal securities laws. Forward-looking statements are subject to various risks, uncertainties and other factors that could cause actual results to differ materially from those stated in such statements. These risks, uncertainties and factors include, but are not limited to: The conflicts in the region; the effects of competition in our industry, and changes in our relationships with optical laboratories, distributors, research and development partners and other third parties; the effects of the international expansion of our operations and our ability to manage our growth, including our ability to manage potential future acquisitions; the effect of global economic conditions in general and conditions in Shamir's industry and target markets in particular; shifts in supply and demand; market acceptance of new products and continuing products' demand; the impact of competitive products and pricing on Shamir's and its customers' products and markets; timely product and technology development/upgrades and the ability to manage changes in market conditions as needed; interest rate fluctuations; and other factors detailed in Shamir's filings with the Securities and Exchange Commission. Shamir assumes no obligation to update the information in this release.

(Tables to follow)

    SHAMIR OPTICAL INDUSTRY LTD.

    Consolidated Balance Sheets
    (US dollars in thousands, except
     share and per share data)     As of December 31,   As of September 30,
                                         2007                  2008
                                                            (Unaudited)

    CURRENT ASSETS:
    Cash and cash equivalents           $18,953             $21,786
    Short-term investment                14,375               3,338
    Trade receivables(1)                 30,719              34,699
    Other receivables and prepaid
     expenses                             7,523              11,130
    Inventory                            27,972              27,985
      TOTAL CURRENT ASSETS               99,542              98,938

    LONG-TERM INVESTMENTS:
    Severance pay fund                    3,089               3,623
    Long-term receivables                 1,299               1,073
    Investments in affiliates             4,437               1,495
      TOTAL LONG-TERM INVESTMENTS         8,825               6,191

    PROPERTY, PLANT AND EQUIPMENT, NET   39,170              41,536
    OTHER ASSETS                          5,412               6,945
    GOODWILL                              7,542               9,455
      TOTAL ASSETS                     $160,491            $163,065

    CURRENT LIABILITIES:
    Short-term bank credit and loans    $15,950             $13,860
    Current maturities of long-term
     loans                                7,689              12,837
    Trade payables                       10,852              10,937
    Accrued expenses and other
     liabilities                         12,735              12,619
      TOTAL CURRENT LIABILITIES          47,226              50,253

    LONG-TERM LIABILITIES:
    Long-term loans                      17,491              11,906
    Capital leases                        4,303               4,190
    Accrued severance pay                 3,337               4,284
    Other long-term liabilities             753                 789
    Deferred income taxes                 1,358               2,199
      TOTAL LONG-TERM LIABILITIES        27,242              23,368

    MINORITY INTERESTS                      800               1,322

    SHAREHOLDERS' EQUITY:
    Share capital
    Common shares of NIS 0.01 par value
      Authorized: 100,000,000 shares
      at December 31, 2007 and September
      30, 2008; Issued and outstanding:
      16,423,740 shares at December 31,
      2007 and September 30, 2008            37                  37
    Additional paid-in capital           66,629              67,222
    Accumulated other comprehensive
     income                               1,628                 215
    Retained earnings                    16,929              20,648
      TOTAL SHAREHOLDERS' EQUITY         85,223              88,122
      TOTAL LIABILITIES AND
       SHAREHOLDERS' EQUITY            $160,491            $163,065

    (1) Net of allowance for doubtful accounts of $ 2,140 and $2,256 as of December 31, 2007 and September 30, 2008, respectively.



    SHAMIR OPTICAL INDUSTRY LTD.
    Consolidated Statements of Income
    (US dollars in thousands, except per share data)

                               Three Months Ended      Nine Months Ended
                                  September 30,          September 30,
                                2007        2008       2007         2008
                            (Unaudited) (Unaudited) (Unaudited) (Unaudited)

    Revenues, net             $30,934     $36,118    $89,823     $111,171
    Cost of revenues           14,747      17,098     42,622       51,272
    Gross profit               16,187      19,020     47,201       59,899

    Operating Expenses:
         Research and
          development costs       639         868      1,901        2,607
         Selling and marketing
          expenses              8,961      10,472     26,469       33,527
         General and
          administrative
          expenses              3,418       4,733      9,628       13,308
    Total operating expenses   13,018      16,073     37,998       49,442
    Operating income            3,169       2,947      9,203       10,457

    Financial expenses (income)
     and other, net               (25)        369        133          869
    Income before taxes on
     income                     3,194       2,578      9,070        9,588
    Taxes on income             1,277         379      3,352        2,063
    Income after taxes on
     income                     1,917       2,199      5,718        7,525

    Equity in losses (earnings)
     of affiliates, net            16          11         19          (14)
    Minority interest in losses
     of subsidiaries             (402)        (18)      (934)        (180)
     Net income                $2,303      $2,206     $6,633       $7,719


    Net earnings per share:
            Basic               $0.14       $0.13      $0.41        $0.47
            Diluted             $0.14       $0.13      $0.40        $0.47


    Number of shares:
            Basic              16,418      16,424     16,311       16,424
            Dilutive           16,568      16,527     16,553       16,532




    SHAMIR OPTICAL INDUSTRY LTD.
    Reconciliation of Non-GAAP Operating Income and Net Income
    (US dollars in thousands, except per share data)

                              Three Months Ended        Nine Months Ended
                                 September 30,            September 30,
                                2007       2008         2007        2008
                           (Unaudited) (Unaudited)  (Unaudited) (Unaudited)


    Operating income          $3,169      $2,947      $9,203      $10,457

    Non-GAAP adjustment:
      Stock based
       compensation             (248)        (45)       (741)        (593)
      Amortization of intangible
        assets                  (277)       (344)       (757)      (1,035)
      Compensation to former
       CEO                         -        (434)          -         (434)
    Non-GAAP operating
     income                   $3,694      $3,770     $10,701      $12,519



    Net income                $2,303      $2,206      $6,633       $7,719

    Non-GAAP adjustment:
      Stock based
       compensation             (248)        (45)       (741)        (593)
      Amortization of intangible
       assets, net              (228)       (265)       (616)        (820)
      Compensation to former
       CEO, net                    -        (378)          -         (378)
    Non-GAAP net income       $2,779      $2,894      $7,990       $9,510

    Net earnings per share:
       Basic                   $0.17       $0.18       $0.49        $0.58
       Diluted                 $0.17       $0.18       $0.48        $0.58

    Number of shares:
       Basic                  16,418      16,424      16,311       16,424
       Dilutive               16,568      16,527      16,553       16,532


'/>"/>
SOURCE Shamir Optical Industry Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Shamir Optical Industry Ltd. to Host Conference Call Announcing Third Quarter 2007 Earnings Results
2. Shamir Optical Industry Ltd. to Host Conference Call Announcing Fourth Quarter and Year End 2007 Earnings Results
3. Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2007 Results
4. Shamir Optical Industry Ltd. to Host Conference Call Announcing First Quarter 2008 Earnings Results
5. Shamir Optical Industry Ltd. Reports First Quarter 2008 Results
6. Shamir Optical Industry Purchases Remaining 49% of Altra Trading GmbH
7. Shamir Optical Industry Ltd. to Host Conference Call Announcing Second Quarter 2008 Earnings Results
8. Optical scientist honored for understanding and improving vision
9. Minority patients prefer optical colonoscopy for colorectal cancer screening
10. Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform
11. Optical Coherence Tomography Market to Top $800 Million by 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... "FCPX editors ... customizable inside of Final Cut Pro X," said Christina Austin - CEO of Pixel ... style. Final Cut Pro X users can now reveal the media of ...
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
(Date:6/24/2016)... N.J. , June 24, 2016  Collagen ... the design, development and manufacturing of collagen and ... regeneration announced today that Bill Messer ... and Marketing to further leverage the growing portfolio ... medical devices. Bill joins the Collagen ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... and Markets has announced the addition of the ... their offering. ... products and provides an updated review, including its applications ... covering the total market, which includes three main industries: ...
Breaking Medicine Technology: